Differential binding of the transcription factors Sp1, AP-1, and NFI to the promoter of the human α5 integrin gene dictates its transcriptional activity

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 1, 2009, Pages 57-67

  Gingras, Marie Ève ^a   Masson Gadais, Bénédicte ^a   Zaniolo, Karine ^a   Leclerc, Steeve ^a   Drouin, Régen ^c   Germain, Lucie ^a,b   Guérin, Sylvain L ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ADOLESCENT; ADULT; ARTICLE; CELL DENSITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORNEA EPITHELIUM; DNA BINDING; EPITHELIUM CELL; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHILD; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; IMMUNOPRECIPITATION; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PHYSIOLOGY; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; TRANSCRIPTION INITIATION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHILD; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIUM, CORNEAL; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; INFANT; INFANT, NEWBORN; INTEGRIN ALPHA5; MIDDLE AGED; NFI TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 58249088841     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2059     Document Type: Article

References (58)

1. Wilson SE, Mohan RR, Mohan RR, Ambrosio R Jr, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20:625-637.
2. Nishida T, Tanaka T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol. 1996;7:2-11.
3. Carrier P, Deschambeault A, Talbot M, et al. Characterization of wound reepithelialization using a new human tissue-engineered corneal wound healing model. Invest Ophthalmol Vis Sci. 2008; 49:1376-1385.
4. Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol. 1982;79:264-269.
5. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13:7-12.
6. Dua HS, Gomes JA, Singh A. Corneal epithelial wound healing. Br J Ophthalmol. 1994;78:401-408.
7. Gipson IK, Inatomi T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol. 1995;6:3-10.
8. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
9. Laplante AF, Germain L, Auger FA, Moulin V. Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. FASEB J. 2001;15:2377-2389.
10. Stepp MA, Spurr-Michaud S, Gipson IK. Integrins in the wounded and unwounded stratified squamous epithelium of the cornea. Invest Ophthalmol Vis Sci. 1993;34:1829-1844.
11. Stenn KS, Malhotra R. Epithelialization. In: Cohen KI, Diegelmann RF, Lindblad WJ, eds. Wound Healing: Biochemical and Clinical Aspects. Philadelphia: WB Saunders; 1992;115-127.
12. Cavani A, Zambruno G, Marconi A, Manca V, Marchetti M, Giannetti A. Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J Invest Dermatol. 1993; 101:600-604.
13. Murakami J, Nishida T, Otori T. Coordinated appearance of beta 1 integrins and fibronectin during corneal wound healing. J Lab Clin Med. 1992;120:86-93.
14. Takamiya M, Kumagai R, Nakayashiki N, Aoki Y. A study on mRNA expressions of fibronectin in dermal and cerebral wound healing for wound age estimation. Leg Med (Tokyo). 2006;8:214 -219.
15. Kossmehl P, Schonberger J, Shakibaei M, et al. Increase of fi-bronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med. 2005;83:626-637.
16. Gillis SE, Nagy LE. Deposition of cellular fibronectin increases before stellate cell activation in rat liver during ethanol feeding. Alcohol Clin Exp Res. 1997;21:857-861.
17. Alonso J, Mampaso F, Martin A, Palacios I, Egido J. Changes in the pattern of fibronectin mRNA alternative splicing in acute experimental mesangioproliferative nephritis. Lab Invest. 1999;79:185-194.
18. Labat-Robert J, Szendroi M, Godeau G, Robert L. Comparative distribution patterns of type I and III collagens and fibronectin in human arteriosclerotic aorta. Pathol Biol (Paris). 1985;33:261-265.
19. Vigneault F, Zaniolo K, Gaudreault M, Gingras ME, Guerin SL. Control of integrin genes expression in the eye. Prog Retin Eye Res. 2007;26:99 -161.
20. Rajagopal S, Huang S, Albitar M, Chakrabarty S. Control of fi-bronectin receptor expression by fibronectin: antisense fibronectin RNA downmodulates the induction of fibronectin receptor by transforming growth factor beta1. J Cell Physiol. 1997;170:138-144.
21. Huang S, Varani J, Chakrabarty S. Control of AKR fibroblast phenotype by fibronectin: regulation of cell-surface fibronectin binding receptor by fibronectin. J Cell Physiol. 1994;161:470-482.
22. Birkenmeier TM, McQuillan JJ, Boedeker ED, Argraves WS, Ruoslahti E, Dean DC. The alpha 5 beta 1 fibronectin receptor: characterization of the alpha 5 gene promoter. J Biol Chem. 1991;266: 20544-20549.
23. Corbi AL, Jensen UB, Watt FM. The alpha2 and alpha5 integrin genes: identification of transcription factors that regulate promoter activity in epidermal keratinocytes. FEBS Lett. 2000;474: 201-207.
24. Larouche K, Leclerc S, Salesse C, Guerin SL. Expression of the alpha 5 integrin subunit gene promoter is positively regulated by the extracellular matrix component fibronectin through the transcription factor Sp1 in corneal epithelial cells in vitro. J Biol Chem. 2000;275:39182-39192.
25. Gingras ME, Larouche K, Larouche N, Leclerc S, Salesse C, Guerin SL. Regulation of the integrin subunit alpha5 gene promoter by the transcription factors Sp1/Sp3 is influenced by the cell density in rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44: 3742-3755.
26. Zhao C, Meng A. Sp1-like transcription factors are regulators of embryonic development in vertebrates. Dev Growth Differ. 2005; 47:201-211.
27. Laniel MA, Poirier GG, Guerin SL. Nuclear factor 1 interferes with Sp1 binding through a composite element on the rat poly(ADP-ribose) polymerase promoter to modulate its activity in vitro. J Biol Chem. 2001;276:20766-20773.
28. Nakamura M, Okura T, Kitami Y, Hiwada K. Nuclear factor 1 is a negative regulator of gadd153 gene expression in vascular smooth muscle cells. Hypertension. 2001;37:419-424.
29. Gao B, Jiang L, Kunos G. Transcriptional regulation of alpha(1b) adrenergic receptors (alpha(1b)AR) by nuclear factor 1 (NF1): a decline in the concentration of NF1 correlates with the downregulation of alpha(1b)AR gene expression in regenerating liver. Mol Cell Biol. 1996;16:5997-6008.
30. Beliveau A, Leclerc S, Rouleau M, Guerin SL. Multiple cloning sites from mammalian expression vectors interfere with gene promoter studies in vitro. Eur J Biochem. 1999;261:585-590.
31. Germain L, Auger FA, Grandbois E, et al. Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology. 1999;67:140-147.
32. Boisjoly HM, Laplante C, Bernatchez SF, Salesse C, Giasson M, Joly MC. Effects of EGF, IL-1 and their combination on in vitro corneal epithelial wound closure and cell chemotaxis. Exp Eye Res. 1993; 57:293-300.
33. Masson-Gadais B, Fugere C, Paquet C, et al. The feeder layer-mediated extended lifetime of cultured human skin keratinocytes is associated with altered levels of the transcription factors Sp1 and Sp3. J Cell Physiol. 2006;206:831-842.
34. Pothier F, Ouellet M, Julien JP, Guerin SL. An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol. 1992;11:83-90.
35. Ouellet S, Vigneault F, Lessard M, Leclerc S, Drouin R, Guerin SL. Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells. Nucleic Acids Res. 2006;34:6472-6487.
36. Gaudreault M, Vigneault F, Leclerc S, Guerin SL. Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3. Invest Ophthalmol Vis Sci. 2007;48:3490-3505.
37. Drouin R, Therrien J-P, Angers M, Ouellet S. In vivo DNA analysis. In: Moss T, ed. DNA-Protein Interactions: Principles and Protocols. Totowa, NJ: Humana Press; 2001:175-219.
38. Gipson IK, Watanabe H, Zieske JD. Corneal wound healing and fibronectin. Int Ophthalmol Clin. 1993;33:149-163.
39. Lauweryns B, van den Oord JJ, Volpes R, Foets B, Missotten L. Distribution of very late activation integrins in the human cornea: an immunohistochemical study using monoclonal antibodies. Invest Ophthalmol Vis Sci. 1991;32:2079-2085.
40. Juhasz I, Murphy GF, Yan HC, Herlyn M, Albelda SM. Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. Am J Pathol. 1993;143:1458-1469.
41. Koria P, Andreadis ST. KGF promotes integrin alpha5 expression through CCAAT/enhancer-binding protein-beta. Am J Physiol Cell Physiol. 2007;293:C1020-C1031.
42. Arts J, Herr I, Lansink M, Angel P, Kooistra T. Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. Nucleic Acids Res. 1997;25:311-317.
43. Gopalan SM, Wilczynska KM, Konik BS, Bryan L, Kordula T. Nuclear factor-1-X regulates astrocyte-specific expression of the alpha1- antichymotrypsin and glial fibrillary acidic protein genes. J Biol Chem. 2006;281:13126-13133.
44. Ravichandran V, Sabath BF, Jensen PN, Houff SA, Major EO. Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J Virol. 2006;80:10506-10513.
45. Li L, He S, Sun JM, Davie JR. Gene regulation by Sp1 and Sp3. Biochem Cell Biol. 2004;82:460-471.
46. Ozanne BW, Spence HJ, McGarry LC, Hennigan RF. Transcription factors control invasion: AP-1 the first among equals. Oncogene. 2007;26:1-10.
47. Tsai-Pflugfelder M, Gasser SM, Wahli W. Functional interaction between the estrogen receptor and CTF1: analysis of the vitellogenin gene B1 promoter in yeast. Mol Endocrinol. 1998;12:1525-1541.
48. Galvin KM, Shi Y. Multiple mechanisms of transcriptional repression by YY1. Mol Cell Biol. 1997;17:3723-3732.
49. Xiao H, Lis JT, Xiao H, Greenblatt J, Friesen JD. The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation. Nucleic Acids Res. 1994;22:1966-1973.
50. Rafty LA, Santiago FS, Khachigian LM. NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter. EMBO J. 2002;21:334-343.
51. Adhikary G, Crish J, Lass J, Eckert RL. Regulation of involucrin expression in normal human corneal epithelial cells: a role for activator protein one. Invest Ophthalmol Vis Sci. 2004;45:1080-1087.
52. Wisniewska MB, Ameyar-Zazoua M, Bakiri L, Kaminska B, Yaniv M, Weitzman JB. Dimer composition and promoter context contribute to functional cooperation between AP-1 and NFAT. J Mol Biol. 2007;371:569-576.
53. Murtagh J, Martin F, Gronostajski RM. The nuclear factor I (NFI) gene family in mammary gland development and function. J Mammary Gland Biol Neoplasia. 2003;8:241-254.
54. Zaniolo K, Gingras ME, Audette M, Guerin SL. Expression of the gene encoding poly(ADP-ribose) polymerase-1 is modulated by fibronectin during corneal wound healing. Invest Ophthalmol Vis Sci. 2006;47:4199-4210.
55. Han S, Ritzenthaler JD, Sitaraman SV, Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem. 2006;281:29614-29624.
56. Kang SJ, Kim EK, Kim HB. Expression and distribution of extra-cellular matrices during corneal wound healing after keratomileusis in rabbits. Ophthalmologica. 1999;213:20-24.
57. Clarke AS, Lotz MM, Chao C, Mercurio AM. Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain. J Biol Chem. 1995;270:22673-22676.
58. Natarajan E, Omobono JD 2nd, Jones JC, Rheinwald JG. Co-expression of p16INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. J Investig Dermatol Symp Proc. 2005;10:72-85.